Literature DB >> 9220498

Ultrastructural and phenotypic characterization of CABA I, a new human ovarian cancer cell line.

V Dolo1, A Ginestra, S Violini, S Miotti, C Festuccia, D Miceli, M Migliavacca, C Rinaudo, F M Romano, F Brisdelli, S Canevari, A Pavan, M L Vittorelli.   

Abstract

We have established an ovarian cancer cell line (CABA I) from ascitic fluid obtained from a patient with papillary adenocarcinoma of the ovary prior to drug treatment. The epithelial origin of the cell line was confirmed by morphology and by immunofluorescence analysis using anticytokeratin antibodies. Ultrastructural analysis revealed a very irregular membrane surface and a clear cytoplasm rich in electron-lucent vesicles. CABA I cells grow rapidly in culture (doubling time 18 h) in an anchorage-independent manner. Exogenously added beta-estradiol and epidermal growth factor (EGF) treatments did not influence cell growth rate. FACS analysis to determine the phenotypic profile of tumor-associated antigen, membrane receptor, and adhesion molecule expression indicated that the cell line was positive for different members of the c-erbB family, for alpha 6 and beta 1 integrin receptors, and intensively positive for HLA class I antigens and the folate receptor. Molecular characterization revealed no mutations for c-myc and c-k-ras genes, but did detect an exon 5 mutation in the p53 gene. CABA I cells grew poorly as heterotransplants in nude mice, and tumors showed long latency periods. Because early (15-20) and late (55-60) passage cells maintain the same growth and phenotypic characteristics, the CABA I cell line might provide a good in vitro model system to investigate the cellular and molecular events involved in ovarian carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220498

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  12 in total

1.  Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells.

Authors:  Alessandro Prinetti; Danilo Millimaggi; Sandra D'Ascenzo; Matilda Clarkson; Arianna Bettiga; Vanna Chigorno; Sandro Sonnino; Antonio Pavan; Vincenza Dolo
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

2.  Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

Authors:  V Dolo; S D'Ascenzo; S Violini; L Pompucci; C Festuccia; A Ginestra; M L Vittorelli; S Canevari; A Pavan
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

3.  Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH.

Authors:  Giulia Taraboletti; Sandra D'Ascenzo; Ilaria Giusti; Daniela Marchetti; Patrizia Borsotti; Danilo Millimaggi; Raffaella Giavazzi; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2006-02       Impact factor: 5.715

4.  Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.

Authors:  HanByoul Cho; Eun Suk Kang; Soon Won Hong; Youn Jin Oh; Sun Mi Choi; Sang Wun Kim; Sung Hoon Kim; Young Tae Kim; Kyoung Sun Lee; Yang Kyu Choi; Jae-Hoon Kim
Journal:  Mol Cell Biochem       Date:  2008-08-06       Impact factor: 3.396

5.  Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles.

Authors:  Ilaria Giusti; Sandra D'Ascenzo; Danilo Millimaggi; Giulia Taraboletti; Gaspare Carta; Nicola Franceschini; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

6.  Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.

Authors:  Danilo Millimaggi; Marianna Mari; Sandra D'Ascenzo; Eleonora Carosa; Emmanuele Angelo Jannini; Stanley Zucker; Gaspare Carta; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

7.  Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior.

Authors:  Ilaria Giusti; Marianna Di Francesco; Sandra D'Ascenzo; Maria Grazia Palmerini; Guido Macchiarelli; Gaspare Carta; Vincenza Dolo
Journal:  Cancer Biol Ther       Date:  2018-04-25       Impact factor: 4.742

8.  Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a(1)H NMR study.

Authors:  A Ferretti; S D'Ascenzo; A Knijn; E Iorio; V Dolo; A Pavan; F Podo
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

9.  Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line.

Authors:  V Appierto; E Cavadini; R Pergolizzi; L Cleris; R Lotan; S Canevari; F Formelli
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

10.  The human ovarian cancer cell line CABA I: A peculiar genetic evolution.

Authors:  Ilaria Giusti; Carla Cervelli; Sandra D'Ascenzo; Marianna Di Francesco; Claudio Ligas; Elvira D'Alessandro; Franco Papola; Vincenza Dolo
Journal:  Int J Mol Med       Date:  2016-02-25       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.